Can a tiny sugar dose soothe Newborns' heel prick pain?

NCT ID NCT07784322

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This trial asks whether a smaller 0.2 mL dose of sweet sucrose solution can relieve pain just as well as a larger 0.5 mL dose during routine heel pricks in newborns. Babies up to 28 days old will be randomly assigned to receive one of the two doses before the procedure. Researchers will measure pain scores, crying time, and heart rate to compare the two approaches.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
24% oral sucrose solution
What this could lead to
If the lower dose works as well, it could reduce sugar exposure for newborns while still easing pain during routine heel pricks.
What could go wrong
This is a small, early-stage trial, and the lower dose might not provide the same pain relief. Also, results in this specific newborn unit may not apply to all babies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

Apr 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 28 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Gestational age ≥ 37 weeks. * Aged between 0 hours to 28 days old. * Requiring routine heel prick (e.g. newborn screening). * Parents or legal guardians can read / understand Chinese or English Exclusion Criteria: * Diagnosed with severe congenital malformations, neurological disorders, or known metabolic disorders. * Having received any sedatives or analgesics. * Having feeding intolerance or gastrointestinal disease.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain control in heel prick procedure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Paediatric, Hospital Authority

    Kowloon, 0000, Hong Kong